Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis

Tigecycline is a novel glycylcycline broad-spectrum antibiotic offering good coverage for critically ill patients experiencing complicated infections. A known side effect is a coagulation disorder with distinct hypofibrinogenemia. To date, the information on possible risk factors and outcomes is spa...

Descripción completa

Detalles Bibliográficos
Autores principales: Treml, Benedikt, Rajsic, Sasa, Hell, Tobias, Fries, Dietmar, Bachler, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537220/
https://www.ncbi.nlm.nih.gov/pubmed/34682825
http://dx.doi.org/10.3390/jcm10204702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537220/
https://www.ncbi.nlm.nih.gov/pubmed/34682825
http://dx.doi.org/10.3390/jcm10204702

Ejemplares similares